» Articles » PMID: 15237110

Induction of Antigen-specific Immunologic Tolerance by in Vivo and in Vitro Antigen-specific Expansion of Naturally Arising Foxp3+CD25+CD4+ Regulatory T Cells

Overview
Journal Int Immunol
Date 2004 Jul 9
PMID 15237110
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Naturally arising CD25(+)CD4(+) regulatory T (T(R)) cells can be exploited to establish immunologic tolerance to non-self antigens. In vivo exposure of CD25(+)CD4(+) T cells from normal naive mice to alloantigen in a T cell-deficient environment elicited spontaneous expansion of alloantigen-specific CD25(+)CD4(+) T(R) cells, which suppressed allograft rejection mediated by subsequently transferred naive T cells, leading to long-term graft tolerance. The expanded T(R) cells, which became CD25(low) in the absence of other T cells, stably sustained suppressive activity, maintained expression levels of other T(R) cell-associated molecules, including Foxp3, CTLA-4 and GITR, and could adoptively transfer tolerance to normal mice. Furthermore, specific removal of the T(R) cells derived from originally transferred CD25(+)CD4(+) T(R) cells evoked graft rejection in the long-term tolerant mice, indicating that any T(R) cells deriving from CD25(-)CD4(+) naive T cells minimally contribute to graft tolerance and that natural T(R) cells are unable to infectiously confer significant suppressive activity to other T cells. Similar antigen-specific expansion of T(R) cells can also be achieved in vitro by stimulating naturally present CD25(+)CD4(+) T cells with alloantigen in the presence of IL-2. The expanded CD25(+)CD4(+) T cells potently suppressed even secondary MLR in vitro and, by in vivo transfer, established antigen-specific long-term graft tolerance. Thus, in vivo or in vitro, direct or indirect ways of antigen-specific expansion of naturally arising Foxp3(+)CD25(+)CD4(+) T(R) cells can establish antigen-specific dominant tolerance to non-self antigens, and would also be instrumental in re-establishing self-tolerance in autoimmune disease and antigen-specific negative control of pathological immune responses.

Citing Articles

Animal models for transplant immunology: bridging bench to bedside.

Kang M, Park H, Kim K, Choi D Clin Transplant Res. 2024; 38(4):354-376.

PMID: 39233453 PMC: 11732767. DOI: 10.4285/ctr.24.0029.


Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.

Dittmar D, Pielmeier F, Strieder N, Fischer A, Herbst M, Stanewsky H Nat Commun. 2024; 15(1):3224.

PMID: 38622133 PMC: 11018811. DOI: 10.1038/s41467-024-47575-z.


Too much of a good thing: a review of primary immune regulatory disorders.

Tsilifis C, Slatter M, Gennery A Front Immunol. 2023; 14:1279201.

PMID: 38022498 PMC: 10645063. DOI: 10.3389/fimmu.2023.1279201.


Regulatory T cells in autoimmune kidney diseases and transplantation.

Mikami N, Sakaguchi S Nat Rev Nephrol. 2023; 19(9):544-557.

PMID: 37400628 DOI: 10.1038/s41581-023-00733-w.


Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective.

Sakaguchi S, Kawakami R, Mikami N Immunother Adv. 2023; 3(1):ltad007.

PMID: 37397971 PMC: 10309084. DOI: 10.1093/immadv/ltad007.